{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:27:39Z","timestamp":1793125659500,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaci.2022.09.027","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:14:38Z","timestamp":1665058478000},"page":"1325-1332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Scientific journey to the first FDA-approved drug for eosinophilic esophagitis"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-6332","authenticated-orcid":false,"given":"Marc E.","family":"Rothenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.09.027_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.24.021605.090720","article-title":"The eosinophil","volume":"24","author":"Rothenberg","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nri.2017.95","article-title":"Functions of tissue-resident eosinophils","volume":"17","author":"Weller","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0016-5085(82)80011-5","article-title":"Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis","volume":"83","author":"Winter","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib4","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0016-5085(95)90637-1","article-title":"Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula","volume":"109","author":"Kelly","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/j.1536-4801.1998.tb00820.x","article-title":"Eosinophils in the esophagus: acid is not the only cause","volume":"26","author":"Furuta","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2022.09.027_bib6","first-page":"380","article-title":"Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids","volume":"26","author":"Liacouras","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2022.09.027_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00000478-199904000-00003","article-title":"Allergic esophagitis in children: a clinicopathological entity","volume":"23","author":"Walsh","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2022.09.027_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI10224","article-title":"An etiological role for aeroallergens and eosinophils in experimental esophagitis","volume":"107","author":"Mishra","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.027_bib9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1067\/mai.2001.119917","article-title":"Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response","volume":"108","author":"Straumann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.gastro.2003.07.007","article-title":"Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism","volume":"125","author":"Mishra","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaci.2006.04.046","article-title":"Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses","volume":"118","author":"Akei","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1365-2222.2005.02299.x","article-title":"Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354)","volume":"35","author":"Blanchard","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.09.027_bib13","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s40265-021-01583-1","article-title":"Tralokinumab: first approval","volume":"81","author":"Duggan","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2022.09.027_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.1000471","article-title":"IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway","volume":"185","author":"Zuo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa'ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib17","article-title":"Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.09.027_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2022.09.027_bib19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jaci.2020.09.039","article-title":"Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors","volume":"147","author":"Rochman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.027_bib21","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4049\/jimmunol.0903069","article-title":"Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis","volume":"184","author":"Blanchard","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mi.2013.90","article-title":"Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis","volume":"7","author":"Sherrill","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib23","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00404.2017","article-title":"Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction","volume":"315","author":"Wu","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaci.2022.09.027_bib24","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1038\/s41467-021-26939-9","article-title":"Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis","volume":"12","author":"Shoda","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.027_bib25","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"129","author":"Wen","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.027_bib26","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.4049\/jimmunol.1004159","article-title":"IL-13 receptor alpha1 differentially regulates aeroallergen-induced lung responses","volume":"187","author":"Rothenberg","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.547","article-title":"Common variants at 5q22 associate with pediatric eosinophilic esophagitis","volume":"42","author":"Rothenberg","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2022.09.027_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ng.3033","article-title":"Genome-wide association analysis of eosinophilic esophagitis provides insight\u00a0into the tissue specificity of this allergic disease","volume":"46","author":"Kottyan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2022.09.027_bib29","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1038\/ncomms6593","article-title":"GWAS identifies four novel eosinophilic esophagitis loci","volume":"5","author":"Sleiman","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.027_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2020.10.018","article-title":"Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes","volume":"147","author":"Kottyan","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1534\/g3.118.200901","article-title":"Genetic, inflammatory, and epithelial cell differentiation factors control expression of human calpain-14","volume":"9","author":"Miller","year":"2019","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.jaci.2022.09.027_bib32","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2007.10.024","article-title":"IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids","volume":"120","author":"Blanchard","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.gastro.2021.10.016","article-title":"Loss of endothelial TSPAN12 promotes fibrostenotic eosinophilic esophagitis via endothelial cell-fibroblast crosstalk","volume":"162","author":"Shoda","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi5586","article-title":"Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis","volume":"6","author":"Morgan","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib35","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jaci.2022.02.025","article-title":"Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission","volume":"149","author":"Ben-Baruch Morgenstern","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2016.11.042","article-title":"Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis","volume":"140","author":"Rochman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib38","first-page":"141","article-title":"Creating\u00a0a\u00a0multi-center rare disease consortium - the Consortium of Eosinophilic\u00a0Gastrointestinal Disease Researchers (CEGIR)","volume":"2","author":"Cheng","year":"2017","journal-title":"Transl Sci Rare Dis"},{"key":"10.1016\/j.jaci.2022.09.027_bib39","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2018.10.057","article-title":"Consortium of Eosinophilic Gastrointestinal Disease Researchers: advancing the field of eosinophilic GI disorders through collaboration","volume":"156","author":"Gupta","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/apt.12413","article-title":"Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis","volume":"38","author":"Dellon","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.09.027_bib42","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-230X-11-126","article-title":"Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods","volume":"11","author":"Franciosi","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaci.2022.09.027_bib44","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2022.09.027_bib45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2022.09.027_bib46","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2013.08.046","article-title":"Molecular diagnosis of eosinophilic esophagitis by gene expression profiling","volume":"145","author":"Wen","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2012.06.051","article-title":"Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis","volume":"130","author":"Rothenberg","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaci.2018.05.005","article-title":"New developments in patients with eosinophilic gastrointestinal diseases presented\u00a0at the CEGIR\/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting","volume":"142","author":"Spergel","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2012.07.011","article-title":"Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases","volume":"130","author":"Fiorentino","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2004.11.053","article-title":"The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation","volume":"115","author":"Holgate","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cell.2016.04.020","article-title":"Humanized anti-IL-5 antibody therapy","volume":"165","author":"Rothenberg","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.09.027_bib53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib54","first-page":"OP325","article-title":"A randomized, double-blind, placebo-controlled trial of a novel recombinant, humanized, anti-interleukin-13 monoclonal antibody (RPC4046) in patients with active eosinophilic esophagitis: results of the HEROES study","volume":"4","author":"Hirano","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jaci.2022.09.027_bib55","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cgh.2020.03.036","article-title":"Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis","volume":"19","author":"Dellon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2022.09.027_bib57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2020.03.045","article-title":"An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results","volume":"146","author":"Gann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2022.09.027_bib59","doi-asserted-by":"crossref","first-page":"AB312","DOI":"10.1016\/j.jaci.2021.12.003","article-title":"Dupilumab improves clinical and histologic aspects of disease in adult and adolescent patients with eosinophilic esophagitis at week 24: results from part B of the 3-part LIBERTY EoE TREET study","volume":"149","author":"Rothenberg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib60","doi-asserted-by":"crossref","first-page":"AB210","DOI":"10.1016\/j.jaci.2021.12.688","article-title":"Dupilumab reduces biomarkers of type 2 inflammation in adult and adolescent patients with eosinophilic esophagitis: results from parts A\u00a0and C of a three-part, phase 3 LIBERTY EoE TREET study","volume":"149","author":"Rothenberg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.027_bib61","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V77.9.1859.1859","article-title":"Interleukin-4: a prototypic immunoregulatory lymphokine","volume":"77","author":"Paul","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.027_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2015.01.038","article-title":"History of interleukin-4","volume":"75","author":"Paul","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2022.09.027_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaci.2020.10.017","article-title":"Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants","volume":"147","author":"Lyles","year":"2021","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492201332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492201332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:39:02Z","timestamp":1758793142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492201332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S009167492201332X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.09.027","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scientific journey to the first FDA-approved drug for eosinophilic esophagitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}